Synthes sees recovery in Europe during promising Q4
This article was originally published in Clinica
Executive Summary
Orthopaedic firm Synthes today posted healthy sales growth across all geographies for the fourth quarter of 2010. The results reflect the strong growth which has also been reported by Synthes’s rivals – such as Zimmer, Stryker and Smith & Nephew – and support the view that the ortho market is recovering.